View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Administering indomethacin rectally before the procedure may lower the incidence and severity of post-ERCP pancreatitis, new research suggests.
The study involved 245 patients who received 100 mg of indomethacin in a rectal suppository and 245 who received an inert suppository immediately before a scheduled ERCP. Of the 442 who subsequently underwent ERCP, 22 (5%) developed pancreatitis. Of those 22 patients, 15 had received the placebo and 7 had received indomethacin. Those in the placebo group had a significantly higher incidence of pancreatitis that was moderate to severe.
Pancreatic duct injection is a known risk factor for post-ERCP pancreatitis. Among the 44 patients who underwent this procedure, only 1 from the indomethacin group developed pancreatitis, compared with 8 patients in the placebo group.
Researchers recommend using "this simple, cheap, and safe medication" to prevent post-ERCP pancreatitis or lessen its severity.
Sotoudehmanesh R, et al., Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP, American Journal of Gastroenterology, May 2007.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top